Vascular risk factors and Alzheimer's disease

被引:17
作者
Stewart, R [1 ]
Prince, M [1 ]
Mann, A [1 ]
机构
[1] Inst Psychiat, Old Age Psychiat Sect, London SE5 8AF, England
关键词
Alzheimer's disease; cardiovascular disease; diabetes; hypertension; stroke;
D O I
10.1046/j.1440-1614.1999.00657.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: We aim to summarise the recent and accumulating epidemiological research which suggests that cardiovascular disease and vascular risk factors play an important role as risk factors for Alzheimer's disease (AD) in later life. Method: The epidemiological literature is summarised in considering the evidence for such an association, focusing on optimally designed population-based studies. Potential mechanisms of association are considered, drawing on relevant findings from neuroscience. Results: Cardiovascular disease and vascular risk disorders appear to be important factors in the aetiology of AD. However, there is a paucity of prospective studies with an adequate duration of follow-up to investigate the apparent age- and time-dependent nature of these associations. Conclusions: Vascular disorders represent potentially preventable risk factors with an important population impact due to their high prevalence in developed countries. The concept of AD and vascular dementia as clearly distinguishable disorders clinically or aetiologically is becoming increasingly tenuous. A better understanding of the relationship between AD and vascular disorders will depend on a more flexible diagnostic and conceptual framework.
引用
收藏
页码:809 / 813
页数:5
相关论文
共 41 条
[1]   IMPACT OF THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION ON BEHAVIORAL VARIABLES - RESULTS FROM THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM [J].
APPLEGATE, WB ;
PRESSEL, S ;
WITTES, J ;
LUHR, J ;
SHEKELLE, RB ;
CAMEL, GH ;
GREENLICK, MR ;
HADLEY, E ;
MOYE, L ;
PERRY, HM ;
SCHRON, E ;
WEGENER, V .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (19) :2154-2160
[2]  
DELATORRE JC, 1993, NEUROL RES, V15, P146
[3]   BLOOD-PRESSURE AND COGNITIVE PERFORMANCE - THE FRAMINGHAM-STUDY [J].
FARMER, ME ;
WHITE, LR ;
ABBOTT, RD ;
KITTNER, SJ ;
KAPLAN, E ;
WOLZ, MM ;
BRODY, JA ;
WOLF, PA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (06) :1103-1114
[4]   Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial [J].
Forette, F ;
Seux, ML ;
Staessen, JA ;
Thijs, L ;
Birkenhäger, WH ;
Babarskiene, MR ;
Babeanu, S ;
Bossini, A ;
Gil-Extremera, B ;
Girerd, X ;
Laks, T ;
Lilov, E ;
Moisseyev, V ;
Tuomilehto, J ;
Vanhanen, H ;
Webster, J ;
Yodfat, Y ;
Fagard, R .
LANCET, 1998, 352 (9137) :1347-1351
[5]   Low blood pressure and dementia in elderly people: The Kungsholmen project [J].
Guo, ZC ;
Viitanen, M ;
Fratiglioni, L ;
Winblad, B .
BRITISH MEDICAL JOURNAL, 1996, 312 (7034) :805-808
[6]   INCREASED AMYLOID PROTEIN-PRECURSOR AND APOLIPOPROTEIN-E IMMUNOREACTIVITY IN THE SELECTIVELY VULNERABLE HIPPOCAMPUS FOLLOWING TRANSIENT FOREBRAIN ISCHEMIA IN GERBILS [J].
HALL, ED ;
OOSTVEEN, JA ;
DUNN, E ;
CARTER, DB .
EXPERIMENTAL NEUROLOGY, 1995, 135 (01) :17-27
[7]   ANTIOXIDANTS AND THE PREVENTION OF CORONARY HEART-DISEASE [J].
HOFFMAN, RM ;
GAREWAL, HS .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (03) :241-246
[8]   Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [J].
Hofman, A ;
Ott, A ;
Breteler, MMB ;
Bots, ML ;
Slooter, AJC ;
vanHarskamp, F ;
vanDuijn, CN ;
Van Broeckhoven, C ;
Grobbee, DE .
LANCET, 1997, 349 (9046) :151-154
[9]   Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies [J].
Holmes, C ;
Cairns, N ;
Lantos, P ;
Mann, A .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 :45-50
[10]   Herpes simplex virus type 1 in brain and risk of Alzheimer's disease [J].
Itzhaki, RF ;
Lin, WR ;
Shang, DH ;
Wilcock, GK ;
Faragher, B ;
Jamieson, GA .
LANCET, 1997, 349 (9047) :241-244